Inhibition of the AKT/mTOR and erbB pathways by gefitinib, perifosine and analogs of gonadotropin-releasing hormone I and II to overcome tamoxifen resistance in breast cancer cells

Gonadotropin-Releasing Hormone (GnRH) agonist triptorelin inhibits estradiol-induced Serum Response Element (SRE) activation and c-fos expression in human endometrial, ovarian and breast cancer cells

Experimental and Clinical Endocrinology & Diabetes ◽

10.1055/s-2005-862970 ◽

2005 ◽

Vol 113 (S 1) ◽

Author(s):

C Gründker ◽

AR Günthert ◽

M Hellriegel ◽

G Emons

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Gnrh Agonist ◽

Breast Cancer Cells ◽

Serum Response Element ◽

Response Element ◽

Releasing Hormone ◽

Fos Expression ◽

Serum Response

Antitumour effect of a gonadotropin-releasing-hormone antagonist (MI-1544) and its conjugate on human breast cancer cells and their xenografts

Journal of Cancer Research and Clinical Oncology ◽

10.1007/bf01212811 ◽

1994 ◽

Vol 120 (10) ◽

pp. 578-584 ◽

Cited By ~ 15

Author(s):

Borb�la Vincze ◽

Istv�n P�lyi ◽

D�ra Daubner ◽

Adrienn K�lnay ◽

G�bor Mez� ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Human Breast Cancer ◽

Breast Cancer Cells ◽

Human Breast Cancer Cells ◽

Human Breast ◽

Antitumour Effect ◽

Expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression

Gynecological Endocrinology ◽

10.1080/09513590802095845 ◽

2008 ◽

Vol 24 (6) ◽

pp. 331-338 ◽

Cited By ~ 8

Author(s):

Antje Schubert ◽

Hiltrud Schulz ◽

Günter Emons ◽

Carsten Gründker

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Nuclear Factor Κb ◽

Nuclear Factor ◽

Rankl Expression ◽

Releasing Hormone ◽

Receptor Activator

Modulation of proliferation by gonadotropin-releasing hormone receptors in breast cancer cells

Biomedical Research Journal ◽

10.4103/2349-3666.240662 ◽

2014 ◽

Vol 1 (1) ◽

pp. 71 ◽

Cited By ~ 1

Author(s):

AnjaliA Karande ◽

Sunil Gangadharan

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Hormone Receptors ◽

Signaling and Antiproliferative Effects of Type I and II Gonadotropin-Releasing Hormone Receptors in Breast Cancer Cells

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.2003-030787 ◽

2004 ◽

Vol 89 (4) ◽

pp. 1823-1832 ◽

Cited By ~ 21

Author(s):

Ann R. Finch ◽

Lisa Green ◽

James N. Hislop ◽

Eamonn Kelly ◽

Craig A. McArdle

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Hormone Receptors ◽

Type I ◽

Antiproliferative Effects ◽

Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells

Gynecological Endocrinology ◽

10.1080/09513590701668882 ◽

2008 ◽

Vol 24 (1) ◽

pp. 24-29 ◽

Cited By ~ 7

Author(s):

Stefanie Fister ◽

Lars Schlotawa ◽

Andreas R. Günthert ◽

Günter Emons ◽

Carsten Gründker

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Hormone Receptor ◽

Breast Cancer Cells ◽

Gonadotropin Releasing Hormone Receptor

Receptor Expression ◽

Releasing Hormone ◽

Hormone Receptor Expression ◽

Induced Apoptosis ◽

Faculty Opinions recommendation of LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734203067.793551626 ◽

2018 ◽

Author(s):

Wafik El-Deiry ◽

Shuai Zhao

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Tamoxifen Resistance ◽

Cyclin D

CD63 + Cancer‐Associated Fibroblasts Confer Tamoxifen Resistance to Breast Cancer Cells through Exosomal miR‐22

Advanced Science ◽

10.1002/advs.202002518 ◽

2020 ◽

Vol 7 (21) ◽

pp. 2002518

Author(s):

Yuan Gao ◽

Xiaoju Li ◽

Cheng Zeng ◽

Chenlin Liu ◽

Qiang Hao ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Tamoxifen Resistance ◽

Cancer Associated Fibroblasts

Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype

Molecular and Cellular Endocrinology ◽

10.1016/j.mce.2006.10.006 ◽

2007 ◽

Vol 264 (1-2) ◽

pp. 44-49 ◽

Cited By ~ 31

Author(s):

Grazia Graziani ◽

Lucio Tentori ◽

Alessia Muzi ◽

Matteo Vergati ◽

Giuseppe Tringali ◽

...

Keyword(s):

Breast Cancer ◽

Cell Growth ◽

Cancer Cells ◽

Human Breast Cancer ◽

Breast Cancer Cells ◽

Receptor Subtype ◽

Corticotropin Releasing Hormone ◽

Human Breast Cancer Cells ◽

Human Breast ◽

Increased expression of enolase α in human breast cancer confers tamoxifen resistance in human breast cancer cells

Breast Cancer Research and Treatment ◽

10.1007/s10549-009-0492-0 ◽

2009 ◽

Vol 121 (3) ◽

pp. 539-553 ◽

Cited By ~ 62

Author(s):

Shih-Hsin Tu ◽

Chih-Chiang Chang ◽

Ching-Shyang Chen ◽

Ka-Wai Tam ◽

Ying-Jan Wang ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Human Breast Cancer ◽

Breast Cancer Cells ◽

Tamoxifen Resistance ◽

Human Breast Cancer Cells ◽

Human Breast